Mol Cancer Ther
From Bioblast
Revision as of 15:49, 5 March 2019 by Plangger Mario (talk | contribs) (Created page with "{{Journal |Title=[http://mct.aacrjournals.org/ Molecular Cancer Therapeutics] }}")
Journal title and website | Molecular Cancer Therapeutics |
---|
Publications
Reference | Published | View | |
---|---|---|---|
Teh 2019 Mol Cancer Ther | Teh JT, Zhu WL, Newgard CB, Casey PJ, Wang M (2019) Respiratory capacity and reserve predict cell sensitivity to mitochondria inhibitors: mechanism-based markers to identify metformin-responsive cancers. Mol Cancer Ther 18:693-705. | 2019 | PMID: 30824582 Open Access |
Schlaepfer 2014 Mol Cancer Ther | Schlaepfer IR, Rider L, Rodrigues LU, Gijรณn MA, Pac CT, Romero L, Cimic A, Sirintrapun SJ, Glodรฉ LM, Eckel RH, Cramer SD (2014) Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol Cancer Ther 13:2361-71. | 2014 | PMID:25122071 Open Access |